R&D Systems™ Recombinant Human B7-H7 Fc Biotinylated Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its binding ability in a functional ELISA. When Recombinant Human TMIGD2/CD28H Fc Chimera (Catalog # 8316-TR ) is immobilized at 0.125 μg/mL, 100 μL/well, the concentration of Biotinylated Recombinant Human B7-H7/HHLA2 Fc Chimera that produces 50% of the optimal binding response is 0.025-0.125 μg/mL.

Specifications

• Accession Number: Q9UM44
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 11148
• Molecular Weight (g/mol): M.W. (theoretical): 64 kDa (unlabeled)
• Name: B7H7, HERV-H LTR-associating 2, HERV-H LTR-associating protein 2, HHLA2, Human endogenous retrovirus-H long terminal repeat-associating protein 2
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human B7-H7/HHLA2 protein Human B7-H7/HHLA2 (Ile23-Asn344) (N-terminus) Accession # Q9UM44 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 2 weeks, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Biotin
• Species: Human
• Reconstitution: Reconstitute at 200 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: B7-H7/HHLA2